Pharma/ Biotechnology Investments Specialist, Vasuda Capital Management

Dr. Bhavneesh Sharma, MD, MBA

Pharma/ Biotechnology Investments Specialist

Vasuda Capital Management

Equity Bottom-Up

Dr. Agarwal’s Eye Hospital / Equity Bottom-Up

<p>Shares of Indian healthcare company, <a href="https://www.smartkarma.com/entities/23713" target="_blank" data-smartkarma-citation="entities:23713:1">Dr. Agarwal’s Eye Hospital (DAEH IN)</a>, that operates 60 eye hospitals in 14 countries, have been surging recently. Although we like the long-term growth story of the company, we feel that the share price has got ahead of the fundamentals (like operating margin, revenue and operating income growth, ROIC etc.), and could be due for a short-term correction.</p>

Shares of Indian healthcare company, Dr. Agarwal’s Eye Hospital (DAEH IN), that operates 60 eye hospitals in 14 countries, have been surging recently. Although we like the long-term growth story of the company, we feel that the share price has got ahead of the fundamentals (like operating margin, revenue and operating income growth, ROIC etc.), and could be due for a short-term correction.

Shares Appear Overvalued and Could Be Due for a Short-Term Correction (10-15%).